Science Explorer Back to mapMap
Discussion
Company · San Ramon · United States

Galena Biopharma (United States)

World rank, all time
#26,680
of 34,923
Rank in United States
#5,574
of 7,310
Research works
163
▲ 142% vs 2018-21
Citations
2.2k
13.6 per fractional work
Top-10% rate
9.0%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
37%
world 40%
International
43%
world 18%

Which fields of science does Galena Biopharma (United States) work in?

In 2022-now, 37% of research at Galena Biopharma (United States) is in Health Sciences, 29% in Social Sciences. Its largest fields are Medicine (33%), Social Sciences (12%), Computer Science (8%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 37.2% of its workMedicine: 14 fractional works · 32.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.3% of its workOphthalmology: 1 fractional works · 3.2% of its workSurgery: 1 fractional works · 3.2% of its workPharmacology: 1 fractional works · 3.1% of its workEpidemiology: 1 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.5% of its workOncology: 0 fractional works · 1.1% of its workComplementary and alternative medicine: 0 fractional works · 0.9% of its workHealth Informatics: 0 fractional works · 0.8% of its workNephrology: 0 fractional works · 0.8% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 3.2% of its workGeneral Health Professions: 0 fractional works · 1.2% of its workEmergency Medical Services: 0 fractional works · 1.0% of its workHealth Information Management: 0 fractional works · 0.4% of its workOccupational Therapy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 1.4% of its workResearch and Theory: 0 fractional works · 0.8% of its workNutrition and Dietetics: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 0.1% of its workSocial Sciences: 12 fractional works · 29.1% of its workSocial Sciences: 5 fractional works · 12.2% of its workSociology and Political Science: 2 fractional works · 4.7% of its workEducation: 2 fractional works · 4.2% of its workGeneral Social Sciences: 0 fractional works · 1.2% of its workDemography: 0 fractional works · 0.5% of its workCultural Studies: 0 fractional works · 0.4% of its workLaw: 0 fractional works · 0.4% of its workUrban Studies: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 3 fractional works · 6.7% of its workAccounting: 2 fractional works · 4.6% of its workStrategy and Management: 1 fractional works · 2.2% of its workArts and Humanities: 2 fractional works · 4.1% of its workLanguage and Linguistics: 1 fractional works · 1.6% of its workVisual Arts and Performing Arts: 0 fractional works · 0.8% of its workHistory: 0 fractional works · 0.5% of its workMuseology: 0 fractional works · 0.5% of its workReligious studies: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPsychology: 1 fractional works · 3.0% of its workClinical Psychology: 0 fractional works · 1.1% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.5% of its workNeuropsychology and Physiological Psychology: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.1% of its workEconomics and Econometrics: 1 fractional works · 2.1% of its workDecision Sciences: 0 fractional works · 0.9% of its workManagement Science and Operations Research: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 10 fractional works · 23.4% of its workComputer Science: 3 fractional works · 8.2% of its workInformation Systems: 1 fractional works · 2.4% of its workComputer Vision and Pattern Recognition: 1 fractional works · 2.2% of its workArtificial Intelligence: 1 fractional works · 2.0% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.7% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workComputer Science Applications: 0 fractional works · 0.3% of its workHuman-Computer Interaction: 0 fractional works · 0.3% of its workEngineering: 3 fractional works · 7.4% of its workBuilding and Construction: 1 fractional works · 3.2% of its workComputational Mechanics: 0 fractional works · 1.0% of its workOcean Engineering: 0 fractional works · 0.9% of its workBiomedical Engineering: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workMedia Technology: 0 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 2.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.9% of its workEnvironmental Chemistry: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMathematics: 1 fractional works · 1.7% of its workStatistics and Probability: 0 fractional works · 1.0% of its workApplied Mathematics: 0 fractional works · 0.8% of its workPhysics and Astronomy: 1 fractional works · 1.3% of its workAstronomy and Astrophysics: 0 fractional works · 0.7% of its workNuclear and High Energy Physics: 0 fractional works · 0.4% of its workInstrumentation: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.4% of its workPolymers and Plastics: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.9% of its workPaleontology: 0 fractional works · 0.5% of its workGeophysics: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 0.3% of its workFluid Flow and Transfer Processes: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workLife Sciences: 4 fractional works · 10.3% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 4.7% of its workMolecular Biology: 1 fractional works · 2.0% of its workGenetics: 0 fractional works · 0.9% of its workCell Biology: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.5% of its workCancer Research: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.5% of its workPharmacology: 1 fractional works · 1.5% of its workDrug Discovery: 0 fractional works · 0.4% of its workToxicology: 0 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 0 fractional works · 0.9% of its workCognitive Neuroscience: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.8% of its workALL ITS WORKGalena Biopharma(United States)42fractional works, 2022-now
Life Sciences10%Physical Sciences23%Health Sciences37%Social Sciences29%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine1432.6%
    2. Health Professions13.2%
    3. Nursing11.4%
    4. Dentistry00.1%
    1. Social Sciences512.2%
    2. Business, Management and Accounting36.7%
    3. Arts and Humanities24.1%
    4. Psychology13.0%
    5. Economics, Econometrics and Finance12.1%
    6. Decision Sciences00.9%
    1. Computer Science38.2%
    2. Engineering37.4%
    3. Environmental Science12.3%
    4. Mathematics11.7%
    5. Physics and Astronomy11.3%
    6. Materials Science01.0%
    7. Earth and Planetary Sciences00.9%
    8. Chemical Engineering00.3%
    9. Chemistry00.3%
    1. Biochemistry, Genetics and Molecular Biology24.7%
    2. Pharmacology, Toxicology and Pharmaceutics12.5%
    3. Agricultural and Biological Sciences11.4%
    4. Neuroscience00.9%
    5. Immunology and Microbiology00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.89× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.79× its world share, 0 worksImmunology and Micro…Neuroscience: 0.54× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.18× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.76× its world share, 0 worksChemical EngineeringChemistry: 0.17× its world share, 0 worksChemistryComputer Science: 1.06× its world share, 4 worksComputer ScienceEarth and Planetary Sciences: 0.55× its world share, 0 worksEarth and Planetary …Engineering: 0.49× its world share, 3 worksEngineeringEnvironmental Science: 0.46× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.30× its world share, 0 worksMaterials ScienceMathematics: 1.49× its world share, 1 worksMathematicsPhysics and Astronomy: 0.58× its world share, 0 worksPhysics and AstronomyDentistry: 0.20× its world share, 0 worksDentistryHealth Professions: 1.21× its world share, 1 worksHealth ProfessionsMedicine: 1.69× its world share, 14 worksMedicineNursing: 2.77× its world share, 1 worksNursingArts and Humanities: 1.43× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 2.09× its world share, 3 worksBusiness, Management…Decision Sciences: 0.92× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.99× its world share, 1 worksEconomics, Econometr…Psychology: 0.98× its world share, 1 worksPsychologySocial Sciences: 0.96× its world share, 5 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.2×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.18×1 works
  2. Nursing2.77×1 works
  3. Business, Management and Accounting2.09×3 works
  4. Medicine1.69×14 works
  5. Mathematics1.49×1 works
  6. Arts and Humanities1.43×2 works
  7. Health Professions1.21×1 works
  8. Computer Science1.06×4 works
  9. Economics, Econometrics and Finance0.99×1 works
  10. Psychology0.98×1 works
  11. Social Sciences0.96×5 works
  12. Decision Sciences0.92×0 works
  13. Biochemistry, Genetics and Molecular Biology0.89×2 works
  14. Immunology and Microbiology0.79×0 works
  15. Chemical Engineering0.76×0 works
  16. Physics and Astronomy0.58×0 works
  17. Earth and Planetary Sciences0.55×0 works
  18. Neuroscience0.54×0 works
  19. Engineering0.49×3 works
  20. Environmental Science0.46×1 works
  21. Materials Science0.30×0 works
  22. Agricultural and Biological Sciences0.29×1 works
  23. Dentistry0.20×0 works
  24. Chemistry0.17×0 works

Who are the top researchers at Galena Biopharma (United States)?

Ranked on the quality score, Josef Stuchlík lead among researchers whose main affiliation is Galena Biopharma (United States).

  1. 1 Josef Stuchlík United States · #5,513,359 worldwide 229 citations · 31 works
All ranked researchers at Galena Biopharma (United States)

What are the most cited papers from Galena Biopharma (United States)?

The most cited paper from Galena Biopharma (United States) is "Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure" (Paul Gerard Guy Richardson et al., 2016), with 335 citations. Next come "IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma" (308) and "Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity" (291).

Most cited papers
#PaperReleasedCitations
1 Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Paul Gerard Guy Richardson et al. · Blood Open access 29 Jan 2016 335
2 IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma Zhi‐Zhang Yang, Deanna M. Grote, Steven C. Ziesmer et al. · Journal of Clinical Investigation Open access 19 Mar 2012 308
3 Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity Dante J. Marciani · Drug Discovery Today Oct 2003 291
4 Analysis of Five High School Biology Textbooks Used in the United States for Inclusion of the Nature of Science Eugene L. Chiappetta, David A. Fillman · International Journal of Science Education 3 Dec 2007 274
5 A method to quantify major themes of scientific literacy in science textbooks Eugene L. Chiappetta, David A. Fillman, Godrej H. Sethna · Journal of Research in Science Teaching Oct 1991 205
All 62 most cited papers, with filters and sorting

Which keywords describe research at Galena Biopharma (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Corporate Governance, Metabolism, Risk Management, Antioxidant Activity, Cardiovascular Disease, Epidemiology, Type 2 Diabetes and Precision Medicine.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Epidemiology3▲ 1.62×15 topics
  2. Deep Learning2▲ 1.61×12 topics
  3. Cardiovascular Disease2▲ 3.9×8 topics
  4. Inflammation2▲ 1.98×15 topics
  5. Corporate Governance2▲ 5.7×5 topics
  6. Antioxidant Activity2▲ 6.2×4 topics
  7. Machine Learning2◆ 1.15×7 topics
  8. Metabolism2▲ 7.0×6 topics
  9. Education2▲ 2.1×7 topics
  10. Risk Management2▲ 7.5×2 topics
  11. Precision Medicine1▲ 6.1×5 topics
  12. E-Learning1▲ 2.9×3 topics
  13. Healthcare1▲ 2.4×5 topics
  14. Sustainability1▲ 1.20×3 topics
  15. Type 2 Diabetes1▲ 12×2 topics
  16. Cancer1▲ 2.0×10 topics
  17. BIM1▲ 39×1 topic
  18. Caffeine1▲ 142×1 topic
  19. Capitalism1▲ 37×2 topics
  20. Coffee1▲ 142×1 topic
  21. Construction1▲ 18×1 topic
  22. Financial Analysis1▲ 21×1 topic
  23. Innovation1▲ 2.3×6 topics
  24. Investment Analysis1▲ 32×1 topic
  25. Islamic Banking1▲ 6.4×2 topics

Which research topics does Galena Biopharma (United States) publish most on?

By volume in 2022-now: BIM and Construction Integration, Financial Analysis and Corporate Governance, Coffee research and impacts and Islamic Finance and Communication.

  1. 1 BIM and Construction Integration Building and Construction 1 works
  2. 2 Financial Analysis and Corporate Governance Accounting 1 works
  3. 3 Coffee research and impacts Pharmacology 1 works
  4. 4 Islamic Finance and Communication Sociology and Political Science 0 works
  5. 5 Financial Reporting and Valuation Research Strategy and Management 0 works
  6. 6 Political Economy and Marxism Sociology and Political Science 0 works
  7. 7 Lipoproteins and Cardiovascular Health Surgery 0 works
  8. 8 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
  9. 9 Educational Innovations and Technology Information Systems 0 works
  10. 10 Islamic Finance and Banking Studies Accounting 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.2%not open62.8%

World: 40% of research is openly available.

with international co-authors42.8%domestic only57.2%

World: 18% is written across borders.

How has Galena Biopharma (United States)'s research output changed?

Output in 2022-2025 was 142% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Galena Biopharma (United States) as a percentage of every work published that year, 0.00017% in 2024.

still counting0.00020%0.00040%0.00060%Galena Biopharma (United States)0.00024% in 202519801990200020102020

Fractional works of Galena Biopharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Ramon

All research institutions in San Ramon

Share Galena Biopharma (United States)'s ranking

Galena Biopharma (United States) on Science Explorer

A card with Galena Biopharma (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Galena Biopharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.